DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 2.72% to $617.00 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.38% to 5,633.07 and the Dow Jones Industrial Average falling 0.03% to 41,989.96.
This was the stock's second consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 49.06% short of its 52-week high of $1,211.20, which the company reached on August 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ fell 1.49% to $306.92, Moderna Inc. $(MRNA)$ fell 4.20% to $27.16, and Gilead Sciences Inc. $(GILD)$ fell 0.69% to $111.28.
Trading volume (1.1 M) eclipsed its 50-day average volume of 962,080.
Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 01, 2025 16:44 ET (20:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.